Did you know those with #PCOS have an increased risk of #type2 #diabetes? (see https://t.co/Qk5AjvDc6j). Join @DAISyPCOS lead @WiebkeArlt & other @IMSR_UoB researchers for a special #WorldDiabetesDay panel discussion, tomorrow at 11am GMT. Register here: https://t.co/7goDctBJc9
Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Oct 2020 – Apr 2025Where it's discussed
-
X / Twitter11 posts
-
News11 articles
-
YouTube2 videos
-
Facebook2 posts
-
Blogs2 articles
AI synopsis
What people are saying
Overall, the discussions express strong agreement with the study's implications, as seen in comments about increased risks of diabetes and fatty liver in women with PCOS. They also demonstrate active engagement through examples of related health issues and mentions of upcoming panels, showing interest and awareness of the research's relevance.
The discussions consistently acknowledge the link between PCOS, androgen excess, and metabolic risks, showing general support for the article's findings.
Posts highlight a high level of curiosity and concern for health risks like diabetes and fatty liver disease associated with PCOS.
Many comments reference existing research, mention upcoming discussions, and cite specific conditions, indicating active engagement.
The emphasis on health risks and calls for awareness suggest the publication could influence public understanding and clinical considerations.
Abstract in brief
- This study shows that women with polycystic ovary syndrome (PCOS), especially those with higher levels of androgens like testosterone and sex hormone-binding globulin (SHBG), are at a greater risk of developing nonalcoholic fatty liver disease (NAFLD).
- The research used a large UK primary care database to track over 63,000 women with PCOS and compared them to women without PCOS, finding that PCOS increases the likelihood of NAFLD even after accounting for factors like BMI and blood sugar levels.
- Limitations of the study include its retrospective design, lack of detailed diagnostic criteria, and no information on laboratory methods used to measure androgen levels, but overall, it suggests that androgen excess in women with PCOS may contribute to liver disease risk.]
Top posts
Most liked on X and BlueskyWomen with #PCOS have an increased risk of #type2 #diabetes, #hypertension & #fattyliverdisease and these risks increase with increasing severity of androgen excess (see https://t.co/Qk5AjvDc6j). What about cardiovascular disease in PCOS? 4/13
5/7 This is of concern in women, where elevated androgen levels are linked to increased risk of metabolic dysfunction as shown here in a study by @MickOReilly1980 @WiebkeArlt @Nirantharakumar https://t.co/yJzYNh8AiV & https://t.co/t9S23o7fpM https://t.co/2pLEcJVVbj
RT @DaisyPcos: Did you know those with #PCOS have an increased risk of #type2 #diabetes? (see https://t.co/Qk5AjvDc6j). Join @DAISyPCOS lea…
RT @DaisyPcos: Women with #PCOS have an increased risk of #type2 #diabetes, #hypertension & #fattyliverdisease and these risks increase wit…
RT @DaisyPcos: Women with #PCOS have an increased risk of #type2 #diabetes, #hypertension & #fattyliverdisease and these risks increase wit…
All mentions
Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease Risk in Women
This study shows that women with polycystic ovary syndrome, especially those with higher androgen levels, are at increased risk of developing nonalcoholic fatty liver disease, highlighting the need for targeted liver…
Polycystic Ovary Syndrome and Liver Disease Risk: A Longitudinal Study
This study shows that women with polycystic ovary syndrome, especially those with higher levels of androgens like testosterone and SHBG, have an increased risk of developing nonalcoholic fatty liver disease, based on a…
5/7 This is of concern in women, where elevated androgen levels are linked to increased risk of metabolic dysfunction as shown here in a study by @MickOReilly1980 @WiebkeArlt @Nirantharakumar https://t.co/yJzYNh8AiV & https://t.co/t9S23o7fpM https://t.co/2pLEcJVVbj
RT @DaisyPcos: Did you know those with #PCOS have an increased risk of #type2 #diabetes? (see https://t.co/Qk5AjvDc6j). Join @DAISyPCOS lea…
RT @DaisyPcos: Did you know those with #PCOS have an increased risk of #type2 #diabetes? (see https://t.co/Qk5AjvDc6j). Join @DAISyPCOS lea…
RT @DaisyPcos: Did you know those with #PCOS have an increased risk of #type2 #diabetes? (see https://t.co/Qk5AjvDc6j). Join @DAISyPCOS lea…
RT @DaisyPcos: Did you know those with #PCOS have an increased risk of #type2 #diabetes? (see https://t.co/Qk5AjvDc6j). Join @DAISyPCOS lea…
Did you know those with #PCOS have an increased risk of #type2 #diabetes? (see https://t.co/Qk5AjvDc6j). Join @DAISyPCOS lead @WiebkeArlt & other @IMSR_UoB researchers for a special #WorldDiabetesDay panel discussion, tomorrow at 11am GMT. Register here: https://t.co/7goDctBJc9
RT @DaisyPcos: Women with #PCOS have an increased risk of #type2 #diabetes, #hypertension & #fattyliverdisease and these risks increase wit…
RT @DaisyPcos: Women with #PCOS have an increased risk of #type2 #diabetes, #hypertension & #fattyliverdisease and these risks increase wit…
RT @DaisyPcos: Women with #PCOS have an increased risk of #type2 #diabetes, #hypertension & #fattyliverdisease and these risks increase wit…
RT @DaisyPcos: Women with #PCOS have an increased risk of #type2 #diabetes, #hypertension & #fattyliverdisease and these risks increase wit…
Women with #PCOS have an increased risk of #type2 #diabetes, #hypertension & #fattyliverdisease and these risks increase with increasing severity of androgen excess (see https://t.co/Qk5AjvDc6j). What about cardiovascular disease in PCOS? 4/13
DP
KS
VU
FU
PK
EC
WA
CG
HE
SN